Skip to main content
. 2021 Nov 17;12:766391. doi: 10.3389/fimmu.2021.766391

Table 1.

Baseline demographics and clinical characteristics for septic AP patients and noninfectious AP patients.

Variables SP (n = 40) NIP (n = 30) HV (n = 30) p-value
Age (mean (SD)) 47.3 (12.37) 55.8 (10.76) 50.9 >0.05
Female (n (%)) 8 (20) 8 (26.7) 9 (30) >0.05
PCT (ng/ml, median (IQR)) 0.43 (0.17–0.99) 0.27 (0.2–0.8) 0 (0–0.08) >0.05
Lactate (mmol/L, median (IQR)) 2 (1.8–2.4) 1.6 (1.3–1.9) <0.05
CitH3 (pg/ml, median (IQR)) 127.3 (82.4–210.2) 27.5 (21–33.5) 26.5 (20.5–39.75) <0.05
PAD2 (ng/ml, median (IQR)) 3.03 (2.1–3.68) 0.32 (0.21–0.49) 0.16 (0.1–0.26) <0.05
PAD4 (ng/ml, median (IQR)) 3.11 (2.53–4.71) 0.28 (0.14–0.51) 0.12 (0.07–0.21) <0.05
dsDNA (ng/ml, median (IQR)) 913.5 (812–1063) 257 (232.5–294) 89 (65–100) <0.05
Survivals (n (%)) 33 (82.5) 30 (100) <0.05
Length of hospital stay (day, median (IQR)) 28.5 (20.8–57) 13.5 (11.3–16.8) <0.05
Length of ICU stay (day, median (IQR)) 4 (1–7.25) 0 (0–0) <0.05
Total SOFA score (median (IQR)) 5 (3–8) 1 (1–2) <0.05
Respiratory SOFA (median (IQR)) 2 (2–3) 1 (1–2) <0.05
Renal SOFA (median (IQR)) 1 (0–3) 0 (0–0) <0.05
Cardiovascular SOFA (median (IQR)) 0 (0–0) 0 (0–0) <0.05
Neurologic SOFA (median (IQR)) 0 (0–0) 0 (0–0) <0.05
Hepatic SOFA (median (IQR)) 1 (0–1) 0 (0–0) <0.05
Coagulation SOFA (median (IQR)) 0 (0–1) 0 (0–0) <0.05

Categorical variables are shown as number (%). For continuous variables, normally distributed values are shown as mean (SD) while not normally distributed are shown as median (interquartile range Q1/Q3). AP, acute pancreatitis; PCT, procalcitonin; CitH3, citrullinated histone H3; PAD2/4, peptidylarginine deiminase 2/4; ICU, intensive care unit; SOFA, sequential organ failure assessment.